brings you what’s hot and cold on the penny stock charts today!

China Media Group Corp. (OTCBB: CHMD) has gotten a lot of action today. CHMD has seen its stock rise a staggering 161%, trading at 0.011, up 0.007, on volume of 13,934,748, an incredible gain for this company considering the volume at the close on Friday was 47,100.

China Media Group has a registered office in the United States with its main operations in Asia, with offices in China, Hong King, Malaysia and Australia. CHMD aims to become one of China's leading new age advertising and media companies while integrating the traditional advertising of TV, newspapers, magazines, billboards and Internet.

CHMD hit a high today of 0.035 with the day's low of 0.003, on no news. The 52 week-high for CHMD from October 2009 sits at 0.01 with the year low of 0.001 from September 2009.

Advanced Cell Technology Inc. (OTCBB: ACTC) has shaken the charts on volume today trading significantly higher then usual. ACTC is trading at 0.101, up 13.26%, reaching the day's high of 0.105 and touching down on a low of 0.096.

Advanced Cell Technology announced last week that due to its research in therapeutic cell types obtained from induced pluripotent stem cells (iPS) has been featured in several well known media outlets. The article states that iPS cells show abnormal expansion and early cellular aging, raising important questions about the future prospects for iPS cell-based therapies and supporting the use of ACT's embryo-safe single blastomere-derived human embryonic stem cell lines, which do not exhibit these problems. ACTC is a biotechnology company applying cellular technology in the field of regenerative medicine.

Adventrix Pharmaceuticals Inc. (OTCBB: ANX) has levelled off on the charts today. ANX is trading at 0.312, up 1.07%, slightly under the day's high of 0.315, touching on the day's low of 0.298, and well under the average trading volume. ANX was actively trading since the start of the year, surging in volume and reaching the 52 week-high mid January of 0.52. Back in January ANX announced that it had completed the sale of its Series E convertible preferred stock for gross proceeds of approximately $19 million.

Since its 52 week-high shares of ANX have been bouncing from the high 0.20's to mid 30's. ANX is a pharmaceutical company whose main products are aimed to improve the performance of existing cancer treatments by focusing on their safety and use.